Rainbow Acoustic Monitoring (RAM) in Patients Weighing up to 10kg

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The objective of this clinical investigational study is to compare the acoustic respiration rates (RRa) obtained using the INVSENSOR0004 sensor in the subjects up to 10 kg with the respiration rates determined by manual annotations (RRref), and when applicable with capnography respiration rate (RRcap).

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT06140433` - Vital Signs Camera Study	N/A

NCT number	NCT03482505
Study type	Interventional
Source	Masimo Corporation
Contact
Status	Terminated
Phase	N/A
Start date	March 12, 2018
Completion date	August 31, 2018

Rainbow Acoustic Monitoring (RAM) in Patients Weighing up to 10kg Comparison Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms